Related Experiment Video
Updated: May 30, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
Adipogenesis and insulin sensitivity in obesity are regulated by retinoid-related orphan receptor gamma
Bettina Meissburger1, Jozef Ukropec, Eva Roeder
1ETH Zürich, Institute of Food Nutrition and Health, Schwerzenbach, Switzerland.
Abstract:
Obesity is a well-known risk factor for the development of secondary complications such as type 2 diabetes. However, only a part of the obese population develops secondary metabolic disorders. Here, we identify the transcription factor retinoid-related orphan receptor gamma (RORγ) as a negative regulator of adipocyte differentiation through expression of its newly identified target gene matrix metalloproteinase 3. In vivo differentiation of adipocyte progenitor cells from Rorγ-deficient mice is enhanced and obese Rorγ(-/-) mice show decreased adipocyte sizes. These small adipocytes are highly insulin sensitive, leading to an improved control of circulating free fatty acids. Ultimately, Rorγ(-/-) mice are protected from hyperglycemia and insulin resistance in the state of obesity. In adipose stromal-vascular fraction from obese human subjects, Rorγ expression is correlated with adipocyte size and negatively correlated with adipogenesis and insulin sensitivity. Taken together, our findings identify RORγ as a factor, which controls adipogenesis as well as adipocyte size and modulates insulin sensitivity in obesity. RORγ might therefore serve as a novel pharmaceutical target to treat obesity-associated insulin resistance.
Insights
Retinoid-related orphan receptor gamma (RORγ) negatively regulates fat cell development. Blocking RORγ improves insulin sensitivity and protects against obesity-related metabolic disorders like type 2 diabetes.
Area of Science:
- Metabolic disease research
- Molecular endocrinology
- Adipocyte biology
Background:
- Obesity is a major risk factor for metabolic complications, including type 2 diabetes.
- However, not all obese individuals develop metabolic disorders, suggesting underlying regulatory mechanisms.
- Identifying factors that control adipocyte function is crucial for understanding metabolic health.
Purpose of the Study:
- To investigate the role of retinoid-related orphan receptor gamma (RORγ) in regulating adipocyte differentiation and function.
- To determine if RORγ influences insulin sensitivity and metabolic health in obesity.
- To explore RORγ as a potential therapeutic target for obesity-associated insulin resistance.
Main Methods:
- Investigated RORγ's role in adipocyte differentiation using mouse models (Rorγ-deficient mice).
- Analyzed adipocyte size, insulin sensitivity, and metabolic parameters (hyperglycemia, insulin resistance) in obese Rorγ(-/-) mice.
- Examined RORγ expression in adipose tissue from obese human subjects and correlated it with adipocyte size and insulin sensitivity.
Main Results:
- RORγ acts as a negative regulator of adipocyte differentiation, partly via its target gene matrix metalloproteinase 3.
- Rorγ-deficient mice exhibited enhanced adipocyte progenitor cell differentiation and smaller adipocytes when obese.
- Obese Rorγ(-/-) mice showed improved insulin sensitivity, better free fatty acid control, and protection against hyperglycemia and insulin resistance.
- In humans, RORγ expression in adipose tissue correlated with adipocyte size and inversely with adipogenesis and insulin sensitivity.
Conclusions:
- RORγ controls adipogenesis and adipocyte size, thereby modulating insulin sensitivity in obesity.
- RORγ is identified as a key factor linking obesity to insulin resistance.
- RORγ represents a promising novel pharmaceutical target for treating obesity-associated insulin resistance.
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
Obesity
PI3K/mTOR/AKT Signaling Pathway
Type II Diabetes II: Pathophysiology
TGF - β Signaling Pathway

